LFSC Top Holdings & Constituents
LFSC, offered by F/m Investments, holds 40 reported positions across $74.7M in assets. Its largest holdings are Cogent Biosciences Inc (COGT) (9.05%), LivaNova PLC (LIVN) (7.36%), and TransMedics Group Inc (TMDX) (5.26%). The 5 biggest positions account for 31.13% of reported assets. The table below lists every reported holding with its portfolio weight and market value in US dollars — open any constituent to research its own performance.
| Position | Weight | Market Value |
|---|---|---|
COGT Cogent Biosciences Inc | 9.05% | $8.65M |
LIVN LivaNova PLC | 7.36% | $7.04M |
TMDX TransMedics Group Inc | 5.26% | $5.03M |
MIRM Mirum Pharmaceuticals Inc | 4.84% | $4.63M |
TVTX Travere Therapeutics Inc | 4.63% | $4.43M |
Holdings data comes from the latest SEC Form N-PORT-P filing for this fund, covering the reporting period ended Feb 28, 2026. Market values are reported in US dollars, and each weight represents the position's share of reported fund assets. Cash, derivatives, and rounding can mean displayed weights do not total 100%. Funds rebalance and file on a schedule, so this page may not reflect intraday or post-filing changes.